Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.evoqremedies.com | |
Market Cap | 19.31 Cr. | |
Enterprise Value(EV) | 24.38 Cr. | 2022-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.80 | Trailing Twelve Months Ending 2022-03 |
Price-Earning Ratio (PE) | 17.70 | Trailing Twelve Months Ending 2022-03 |
Industry PE | 40.91 | Trailing Twelve Months Ending 2022-03 |
Book Value / Share | 17.03 | Trailing Twelve Months Ending 2022-03 |
Price to Book Value | 0.83 | Calculated using Price: 14.20 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 1.36 Cr. | 13,600,000 Shares |
FaceValue | 10 | |
Company Profile | ||
No Company Profile found. |
1 Day |
|
|
1 Week |
|
-8.39% |
1 Month |
|
|
3 Month |
|
-7.49% |
6 Month |
|
+1.50% |
1 Year |
|
|
2 Year |
|
|
5 Year |
|
|
10 Year |
|
4 years | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 49.78 | 1.34 | 186.89 | 9.13 | |
Return on Capital Employed (%) | 68.94 | 2.69 | 246.90 | 9.12 | |
Return on Assets (%) | 0.52 | 0.01 | 10.45 | 5.27 |
Particulars | 4 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Shh. Funds | 0 | 0 | 1 | 23 | |
Non Curr. Liab. | 0 | ||||
Curr. Liab. | 2 | 6 | 7 | 10 | |
Minority Int. | |||||
Equity & Liab. | 2 | 6 | 8 | 33 | |
Non Curr. Assets | |||||
Curr. Assets | 2 | 6 | 8 | 33 | |
Misc. Exp. not W/O | |||||
Total Assets | 2 | 6 | 8 | 33 |
Particulars | 4 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Net Sales | 3 | 9 | 10 | 17 | |
Other Income | |||||
Total Income | 3 | 9 | 10 | 17 | |
Total Expenditure | -3 | -9 | -9 | -15 | |
PBIDT | 0 | 1 | 1 | ||
Interest | |||||
Depreciation | |||||
Taxation | 0 | 0 | |||
Exceptional Items | |||||
PAT | 0 | 1 | 1 | ||
Adjusted EPS | 10 | 1 |
Particulars | 4 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | -28 | |
Cash Fr. Inv. | |||||
Cash Fr. Finan. | 29 | ||||
Net Change | 0 | 0 | 0 | 2 | |
Cash & Cash Eqvt | 0 | 0 | 2 |
Fri, 27 Jan 2023
Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Pursuant to Regulation 32 of the SEBI Listing Regulations and SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24 2019 please note that there are no deviation(s) or variation(s) in respect of the utilization of the proceeds of the Initial Public Offer (IPO) of the Company during the Half Year ended 30th September 2022 as mentioned in the object clause of the Prospectus dated 8th March 2022 Please find enclosed herewith a statement in this regard.A statement confirming that there is no deviation or variation in the utilisation of these proceeds is enclosed herewith. |
Mon, 09 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 With reference to the captioned subject we hereby submit the confirmation Certificate received from M/s. Accurate Securities & Registry Private Limited Registrar and Share Transfer Agent (RTA) as per Regulation 74(5) of the Securities and Exchange Board India (Depository and Participant) Regulations 2018 for the Quarter and Nine Months ended on 31st December 2022. |
Tue, 08 Nov 2022
Submission Of Revised Unaudited Financial Results For The Half Year Ended On 30Th September 2022 Along With Limited Review Report In reference to captioned subject and pursuant to Regulation 33(3) (d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are hereby submitting the Revised Unaudited Financial Results for the Half Year ended on 30th September 2022 along with Limited Review Report. Kindly take this revised result on your record and oblige us.Thanking You.Yours Faithfully |
Wed, 01 Feb 2023 |
|
|
|
|
|